Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1

NCT06435026 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

HIV
Prevention
Pregnancy

Interventions

DRUG: FTC/TDF 200mg/300mg
DRUG: FTC/TDF 300mg/450mg
DRUG: FTC/TDF 400mg/600mg

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]